Company intelligence / Profile preview

Erfa

Westmount, Quebec, Canada

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Erfa is a Canadian specialty pharmaceutical company that focuses on the commercialization of niche and essential medicines across various therapeutic categories. The company is best known for its endocrinology portfolio, specifically Erfa Thyroid, a desiccated thyroid extract used for the treatment of hypothyroidism. Erfa also provides products in therapeutic areas including cardiology, pain management, and nutrition. Following its acquisition by Searchlight Pharma in 2021, Erfa continues to operate as a key provider of specialty pharmaceuticals in the Canadian market.

Therapeutic areas: HematologyEndocrinology
Modalities: HormoneSmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Erfa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erfa.

Explore the full profile